Form 4: Curtiss-Wright CFO K. Christopher Farkas Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


K. Christopher Farkas, CFO of Curtiss-Wright, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

  • On March 17, 2025, K. Christopher Farkas, CFO of Curtiss-Wright, acquired 2,243 shares of common stock through the vesting of restricted stock units (RSUs) granted on March 17, 2022, under the company's 2014 Omnibus Incentive Plan.
  • These RSUs cliff vested after a three-year period.
  • On March 18, 2025, Farkas sold 922 shares of common stock at an average price of $325.47, with prices ranging from $324.21 to $327.35.
  • The sale was conducted to cover tax obligations associated with the vesting of the RSU award, in compliance with the company's share ownership guidelines.
  • Following these transactions, Farkas beneficially owns 14,033 shares of Curtiss-Wright common stock.
  • He also holds 10,894 derivative securities, which include dividend credits earned on prior outstanding grants.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to executive stock transactions, with no inherent positive or negative sentiment. It reflects standard compensation practices.

Positives

  • The transactions are in compliance with the company's share ownership guidelines, indicating adherence to internal policies.
  • The vesting of RSUs reflects the executive's continued service and contribution to the company over the three-year vesting period.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation and tax planning. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.

Comparison to Industry Standards

  • Executive compensation packages often include restricted stock units that vest over time.
  • Selling shares to cover tax obligations upon vesting is a standard practice among executives.
  • The reported average selling price of $325.47 is within a normal range for stock transactions.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax planning.

Key Dates

DateDescription
03/17/2022Date of original RSU grant under the Company's 2014 Omnibus Incentive Plan.
03/16/2025Date the Restricted Stock Units vested.
03/17/2025Date of RSU vesting and share acquisition.
03/18/2025Date of share sale.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.